Experimental study of anticancer mechanism of Jianpi Liqi Granules in H22 hepatic cancer mice

Meng Zhiqiang
2011-01-01
Abstract:Objective: To explore the antitumor effect and its mechanism of Jianpi Liqi Granules on H22 hepatic cancer mice.Methods: After establishing the H22 hepatic cancer mice model by cell vaccination,the cancer-bearing mice were divided into 3 groups: Jianpi Liqi Granules group,Jianpi Liqi Granules Pixu group and control group(regular cancer-bearing mice),with 10 cases in each group.The effect of Jianpi Liqi Granules on the weight of mice,antitumor rate,serum DNA,and the expression of VEGF,Bcl-2,C-myc and PCNA was examined in H22 hepatic cancer mice.Results: A significant weight loss was observed in control group,compared to the Jianpi Liqi Granules group and Jianpi Liqi Granules PiXu group.The tumor-inhibiting rates were 32.4%(P0.01)and 28.1%(P0.05)in Jianpi Liqi Granules PiXu group and Jianpi Liqi Granules group,respectively,which was significantly higher than that in the control group(P0.05).Compared with the control group,lower serum DNA volume,VEGF expression and C-myc expression were observed both in Jianpi Liqi Granules group,Jianpi Liqi Granules PiXu group(P0.05),while the PCNA expression was similar among the three groups.Specifically,lower VEGF expression and Bcl-2 expression were observed in Jianpi Liqi Granules PiXu group(P0.05),compared with the Jianpi Liqi Granules group.Conclusion: Jianpi Liqi Granules can significantly inhibite the growth of H22 hepatic cancer cell in mice.The antitumor mechanism may relate to down-regulating the expressions of VEGF,Bcl-2 and C-myc,while reducing the value of circulating plasma DNA.
What problem does this paper attempt to address?